Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Virginia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Virginia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Virginia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Adam Lipman (NPI 1366769911)

Field	Value
Entity Type	Individual
Organization	Adam Lipman
Address	397 Little Neck Rd
City	Virginia Beach
State	VA
ZIP	23452
Taxonomy	Ophthalmology Physician
NPI Enumerated	April 22, 2010

Payer Source	Total Paid
Medicare	$3.7M
Medicaid	$0

Key Findings

This provider’s Medicare billing profile is heavily dominated by intravitreal injection therapies, with J2777 (faricimab-svoa) and J0178 (aflibercept) accounting for the majority of revenue and, together with 67028, representing 84.0% of total Medicare revenue. The code mix—large volumes of anti-VEGF and newer biologic injectables plus frequent intravitreal injection procedure codes—indicates a practice largely focused on retinal disease management and high-volume ophthalmic injection services rather than general ophthalmology or surgical subspecialty work.

Revenue concentration is extreme: J2777 alone generates $1.7M (46.0% of Medicare revenue) and J0178 contributes $1.2M (32.9%), with 67028 adding $188.8K (5.1%). The precomputed top-three share of 84.0% signals reliance on a narrow set of high-cost injectable treatments for most of the provider’s Medicare income, which creates sensitivity to utilization or pricing changes for those specific drugs and related procedures.

This provider appears effectively single-payer in scope: total Medicare revenue is $3.7M while there is no Medicaid billing on file. The absence of Medicaid activity indicates the provider’s Medicare business is the sole documented public payer revenue stream, which may reflect practice demographics, payer contracting choices, or non-participation in state Medicaid programs.

On competitive standing, the provider is a high-volume national outlier for several retinal/ophthalmology services. J2777 ranks #70 of 2039 providers nationally (97th percentile) and J0178 ranks #666 of 3204 (79th percentile), showing notably above-typical volume for faricimab and solid, above-average volume for aflibercept. Additionally, high national percentiles for 92014 (98th, extreme outlier) and 92134 (98th, extreme outlier) suggest unusually large volumes of comprehensive eye exams and retinal imaging relative to peers.

Several ancillary codes further reinforce a retina-centric, procedure-driven practice: 92014 (1.6K claims) and 92134 (2.7K claims) are both extreme outliers, indicating very high throughput of established comprehensive exams and retinal imaging to support ongoing injection therapy. The combination of frequent imaging and exam codes with intensive drug injection billing is consistent with chronic management of retinal conditions such as wet AMD or diabetic macular edema.

While most additional CPT/HCPCS codes are within typical national ranges, a few procedure codes show elevated standing that aligns with a retina-focused surgical capability: 67145 ranks #32 of 861 providers nationally (96th percentile) for laser retinopexy, and 67042 is mid-range (67th percentile) for more invasive vitreoretinal procedures. These patterns suggest the practice manages a spectrum from medical retina injections to some laser and surgical interventions rather than only office-based injections.

The provider has an established NPI tenure, enumerated on 2010-04-22 (~16 years ago), indicating a longstanding presence in the market. That tenure combined with concentrated, high-volume injectable and imaging services suggests an experienced retinal practice that has scaled a specific treatment workflow over many years.

Less material revenue streams are present but not a major source of Medicare income: drug codes like J3490, J2781, and J7312 and a range of E/M and diagnostic codes each contribute small single-digit percentages to total Medicare revenue. These smaller items reflect typical ancillary services and occasional alternative therapeutics but do not meaningfully diversify the provider’s revenue base away from the dominant faricimab and aflibercept treatments.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

27 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2777	Injection, faricimab‑svoa, 0.1 mg	58,500	$30	$1.7M
J0178	Injection, aflibercept, 1 mg	1,750	$690	$1.2M
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,080	$90	$188.8K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	1,550	$90	$141.4K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,670	$30	$80K
J3490	Unclassified drugs	40	$1,930	$77.1K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	590	$120	$70.2K
92012	For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any…	650	$60	$41.7K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	220	$160	$34.7K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	260	$90	$23.8K

Showing 1–10 of 27

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 27 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Virginia Distribution

Adam Lipman — 4 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Virginia

Full comparison — all codes billed, vs. state median

27 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	35	80	1,400	$690	$1.1M
J2777	2	60	13,200	$30	$517.1K
67028	16	90	1,000	$90	$107.1K
J2781	9	20	560	$120	$86.6K
J7312	12	20	240	$160	$42.5K
67042	10	20	20	$1,130	$33.8K
92014	42	870	170	$80	$32.8K
99214	4,107	12,890	140	$80	$21K
J3490	71	110	60	$280	$20.5K
J9035	15	60	170	$50	$19.9K

Showing 1–10 of 27

Related Providers

Other providers that share a Tax Identification Number (TIN) with Adam Lipman, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Lahey Clinic, Inc.	MA	Internal Medicine Physician	$0	$5.7M
Barry Mandell	VA	Ophthalmology Physician	$3.3M	$0
Kendra Klein-mascia	MA	Ophthalmology Physician	$1.4M	$0
David Ramsey	MA	Ophthalmology Physician	$1M	$0
Jeffrey Marx	MA	Ophthalmology Physician	$933.2K	$0
Stephen Lyle	MA	Anatomic Pathology Physician	$852.2K	$40.3K
Chieke Udom	MA	Hospitalist Physician	$629.2K	$0
Syed Akbar	IL	Diagnostic Radiology Physician	$280.8K	$223.7K
Fina Barouch	MA	Retina Specialist (Ophthalmology) Physician	$450.7K	$0
David Winger	MN	Diagnostic Radiology Physician	$413.8K	$1.6K

Nearby Providers

Other providers in the same ZIP code as Adam Lipman, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Support Services Of Virginia, Inc.	VA	Developmentally Disabled Services Day Training Agency	$0	$76.1M
Crescent Counseling & Casework Services Inc.	VA	Community/Behavioral Health Agency	$0	$25.3M
Hope Care & Love Home Healthcare Services LLC	VA	Home Health Agency	$0	$19M
Rehabilitation Associates Inc	VA	Pediatric Physical Therapist	$0	$18.2M
Family First Home Healthcare ,LLC	VA	Home Health Agency	$0	$17.4M
Seven Summits Family Services, LLC	VA	Community/Behavioral Health Agency	$0	$9.9M
Circle Of Life, LLC	VA	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$9.3M
Right Path Treatment Center LLC	VA	Addiction Medicine (Internal Medicine) Physician	$0	$9M
Reign Integrated Services	VA	Behavior Analyst	$0	$8.3M
C & R Divine Hands Of Care	VA	Home Health Agency	$0	$8.1M

Adam Lipman — Billing Profile & Reimbursement Data

Sign up for Adam Lipman — Billing Profile & Reimbursement Data policy alerts

Adam Lipman — Billing Profile & Reimbursement Data

Sign up for Adam Lipman — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References